RT Journal
A1 Berkowitz SA, Johansen KL
T1 Behavioral medicine trial design: Time for a change—reply
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 2012
FD September 24
VO 172
IS 17
SP 1350
OP 1351
DO 10.1001/archinternmed.2012.3223
UL http://dx.doi.org/10.1001/archinternmed.2012.3223
AB 
We wish to thank Lavoie and colleagues for their thoughtful letter. We agree with their suggestion that interventions in behavioral medicine be viewed analogously to phase 1, 2, and 3 clinical trials in drug development and thank them for pointing out the recommendations of the Office of Behavioral and Social Science Research.